This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Der, H. Articles by Soltesz, P. Search for Related Content PubMed PubMed Citation Articles by Der, H. Articles by Soltesz, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB NITROGLYCERIN Social Bookmarking                   What's this?

Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome

3rd Department of Medicine, Institute for Internal Medicine, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary

G. Kerekes

3rd Department of Medicine, Institute for Internal Medicine, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary

K. Veres

3rd Department of Medicine, Institute for Internal Medicine, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary

P. Szodoray

3rd Department of Medicine, Institute for Internal Medicine, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary

J. Toth

Clinical Research Center, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary

G. Lakos

3rd Department of Medicine, Clinical Immunopathology Laboratory, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary

G. Szegedi

3rd Department of Medicine, Institute for Internal Medicine, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary, Autoimmune Research Group of the Hungarian Academy of Sciences and University of Debrecen, Hungary

P. Soltesz

3rd Department of Medicine, Institute for Internal Medicine, University of Debrecen, Medical and Health Science Center, Debrecen, Hungary, soltesz{at}iiibel.dote.hu

Primary antiphospholipid syndrome (APS) is characterized by venous or arterial thrombotic events and/or recurrent abortions, fetal death, preeclasmpsia, eclampsia in the presence of anticardiolipin antibodies or lupus anticoagulant, in the absence of accompanying diseases. Antiphospholipid antibodies can activate endothelial cells, and were recently implicated in atherosclerosis. To assess potential endothelial impairment and early signs of atherosclerosis, flow-mediated (endothelium-dependent) and nitrate-mediated (endothelium independent) vasodilation, as well as von Willebrand factor antigen level and carotid artery intima-media thickness (IMT) were measured in patients with primary antiphospholipid syndrome and in healthy controls. Flow-mediated vasodilation in patients with primary APS was significantly lower than that of controls (3.43 ± 2.86% versus 7.96 ± 3.57%; P < 0.0001). We also found significantly higher von Willebrand antigen levels in patients with primary APS than in the control group (157.91 ± 52.45% versus 125.87 ± 32.8%; P = 0.012). Moreover, carotid artery IMT was significantly larger in the primary APS group compared to controls (0.714 ± 0.2 mm versus 0.58 ± 0.085 mm; P = 0.0037). Our results reflect ongoing endothelial damage and accelerated atherosclerosis in patients with primary APS, and suggest that vasoprotective therapy may be beneficial in the treatment of these patients. Lupus (2007) 16, 497—503.

Key Words: endothelium-dependent vasodilation • primary antiphospholipid syndrome • von Willebrand factor

Lupus, Vol. 16, No. 7, 497-503 (2007)
DOI: 10.1177/0961203307080224


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				F. Bilora, M. T. Sartori, E. Zanon, E. Campagnolo, M. Arzenton, and A. Rossato Flow-Mediated Arterial Dilation in Primary Antiphospholipid Syndrome Angiology, February 1, 2009; 60(1): 104 - 107. [Abstract] [PDF]

				P. Soltesz, H. Der, K. Veres, R. Laczik, S. Sipka, G. Szegedi, and P. Szodoray Immunological features of primary anti-phospholipid syndrome in connection with endothelial dysfunction Rheumatology, November 1, 2008; 47(11): 1628 - 1634. [Abstract] [Full Text] [PDF]